Close Menu

NEW YORK (360Dx) – MdxHealth announced today that it has entered into an agency service agreement with Unilabs for MDxHealth's SelectMDx urine test for prostate cancer.

Under the terms of the agreement, Unilabs will offer SelectMDx to patients of all its clinical labs in France, Portugal, Sweden, Norway, Denmark, Finland, UK, Italy, and Switzerland. Unilabs' medical laboratory in Geneva will perform the SelectMDx service testing. To offer the service throughout its network, Unilabs will purchase SelecMDx CE-market IVD kits from MDxHealth.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.